osseous incorporation (4, 6). Consequently, bony coating prevents a thorough degradation and impedes a continuous remodelling to adjust to biomechanical needs. Ceramics are characterised by poor shear and bending strength with a reasonable compressive strength (7-9). Based on their inferior biomechanical properties and poor resorption, the clinical applications for these are limited.
INTRODUCTION
The treatment of osseous defects remains a challenge in orthopaedic surgery. Autologous bone graft is still defined as the golden standard and shows an extraordinary healing and regeneration capacity based on its osteogenic and osteoconductive potentials with the absence of graftversus-host or foreign-body reactions. Nevertheless, disadvantages, e.g. limited availability and donor-site morbidity, are not to be discounted (1) (2) (3) (4) (5) . Nowadays, a variety of different bone substitutes are available to cope with these problems, but often not enough information is available to guide the clinician with regard to their in vivo behaviour and applicability.
Calcium phosphate ceramics excel in bioactivity, biocompatibility, and osteoconductivity which lead to fast lysis (at 450°C-550°C for 24 hours and subsequent 700°C-900°C for 5 hours), and additional complete removal of all organic structures take place. A sintering procedure (at 1,200°C for 5 hours) results in a crystalline-like structure of over 95% hydroxyapatite. This allows a preservation of the open, trabecular macrostructure, while its conversion into hydroxyapatite with a pore diameter of 100-1,500 µm occurs (16) .
The calcium phosphate ratio ranges from 1.67 to 1.68 (17) . Porosity ranges from 30% to 80% (18) .
Operation and evaluation protocol
The surgical procedures were undertaken under strict aseptic conditions. A control group was not established, because the authors had detected spontaneous fractures associated with untreated critical size defects in a previous study which had shown that the control defects had only undergone partial healing of the defects with no restitutio ad integrum (19) .
The animals were labelled on the 11th, 15th, 18th, and 25th day postoperatively and 3 days before euthanasia, with tetracycline (20 mg/kg body weight), xylenol orange (30 mg/kg body weight), alizarin complexone (20 mg/kg body weight) and tetracycline (20 mg/kg bodyweight) (20) .
The animals were held in groups of 2 to 5 on a farm under adequate living conditions postoperatively and were under close surveillance daily. The pigs were fed pellets twice daily and received water ad libitum. Full weight-bearing was permitted instantaneously after surgery.
The animals were sacrificed according to protocol with an overdose of barbiturate. Tissue blocks with the bone substitute fillings were harvested and processed according to the technique described by Donath (21) . Technovit 9100NEU™ was used as an embedding resin (Heraeus Kulzer, Germany). The planes of the specimens were perpendicular to the axis of the cylindrical defect at a depth of 6 and 7 mm. Fluorescent microscopy was completed using samples of 70 µm in diameter. The analytical studies and digital documentations were undertaken with 3 different wave-length filters of 390-420 nm, 450-490 nm, and 525-545 nm using the microscope Axioplan 2 (Carl Zeiss Jena, Germany). Histological-qualitative examinations were done using toluidine blue stained samples of 20-40 µm. Histomorphometrical evaluation followed semiautomatically using the software KS300™ (Carl Zeiss Jena, Germany). Bone and substitute material were detected and referenced to a predefined area which constituted the original defect area. Therefore, total area of the defect, area within the defect occupied by bone substitute material, and area within the defect occupied by bone were measured. which will be defined as osteotransduction (10).
The objective of this study was the evaluation of 2 different types of resorbable calcium phosphate materials in comparison with a well-established calcium phosphate ceramic, with regard to the parameters bioactivity, osteoconductivity, and resorption rates. Using a critical size defect in a standardised animal model based on the Göttinger minipig, the study design allowed an intra-individual comparison between these bone substitute materials over time.
MATERIALS AND METHODS

Study design
With approval of the local ethics committee (35-9185.81/148/00) 35 Göttinger minipigs (age: 18-32 months; body weight: 28-63 kg) from Ellegaard Minipigs, Denmark, were allocated into 3 follow-up groups on a random draw: 6 weeks (n=11), 12 weeks (n=13), and 52 weeks (n=11). Cylindrical defects (depth: 10 mm; diameter: 7.8 mm) were created in the proximal, medial tibia metaphysis using an internally rinsed tubular, hollow diamond cutter (outer diameter: 7.8 mm; inner diameter: 6.9 mm; MedArtis, Germany) under general anaesthesia (11). Copious irrigation with physiological saline solution was used to limit thermal necrosis of the bone interface. Three different bone substitute materials were implanted randomly either in the left or in the right tibial defect to allow an intra-individual comparative series.
Bone substitutes
Bone Source™ (Stryker GmbH & Co. KG, Duisburg, Germany) is a complete synthetic microcrystalline calcium phosphate cement which consists of a solid phase with 73 wt% tetracalcium phosphate and 27 wt% dicalcium phosphate anhydrate, and a liquid phase which consists of saline (12). The porosity is around 45% with pore size below 6 µm whereas 5% of the former are constituted of pores which range from 2 to 5 nm in diameter (13).
Cementek™ (Teknimed LC, Vic en Bigorre, France) as a calcium phosphate cement consists of a solid and a liquid component. The solid phase is made of a mixture of 38 wt% α-tricalcium phosphate, 49 wt% tetracalcium phosphate, and 13 wt% sodium glycerophosphate. The liquid phase is prepared from 32 wt% lime and 68 wt% phosphoric acid (14). The calcium phosphate ratio ranges from 1.5 to 1.67, and 47% of pores are smaller than 100 nm in diameter (15).
Endobon™ (Biomet Deutschland GmbH, Berlin, Germany) is made of bovine cancellous bone by hydrothermal defatting and calcination. The manufacturing process involves an oxidation of nitrogen and carbon while pyro- Spies et al 
Statistical analysis
One-way analysis of variance followed by a post hoc test (Tamhane-T 2) were applied using the software IBM SPSS Statistics 19. The significance level was set to a p value of <0.05.
RESULTS
No significant intraoperative or postoperative complications occurred. Seventy tissue blocks with the bone substitutes were harvested. Four of these had to be excluded from analysis because they were destroyed during the preparation procedures.
Qualitative histological analysis: 6-week observation interval
The identification of all materials could be easily achieved since each had a characteristic appearance (Tabs. I and II). Osseous incorporation of all materials started from the beginning, and all samples showed osteoblasts and osteoid formation at the interface. The fluorescence staining showed a centripetal ingrowth of bone with deposits directly at the surface of the materials starting with tetracycline ( Fig. 1 ). The absence of any inflammatory processes was noteworthy. Prominent and thickened trabeculae at the interface correlated well with the greatest bony ingrowth for the Cementek™ samples. In accordance with these observations, many polynucleated cells in intimate contact with the cement surface were identified (Fig. 2) . These cells could be detected at all implantation sites for all materials -however, to lesser extent for Bone Source™ and Endobon™. Woven bone was the leading formation for all materials, and the trabeculae of Endobon™ ceramics were incorporated by broad osseous deposits at the interface first. Fibrous tissue with numerous vessels embedded within was detected as void filler in all samples (Tabs. I and II).
Qualitative histological analysis: 12-week observation interval
Fluorescence staining highlights the remodelling processes at all implantation sites with progressive concentration of the labels at the interface, whereas bony ingrowth proceeded centripetally (Tabs. I and III). The latter was promoted by a massive disintegration and degradation of both cements into globuli, whereas the ceramic Endobon™ persisted (Fig. 3) . The osseous reaction at the interface was regressive with less prominent trabeculae. Lamellar bone was formed in the Ce-mentek™ samples to a significant degree after this time Efficacy of Bone Source TM , Cementek TM , Endobon TM in metaphyseal defects 
Qualitative histological analysis: 52-week observation interval
After a year, striking differences between all materials were evident. Further degradation of Bone Source™ could not be detected, whereas the deg-radation of Cementek™ had progressed (Tabs. I and IV). In contrast, Endobon™ was characterised by its persistence and the greatest amount of bone formation within the implantation site ( Fig. 4) . Osseous incorporation of all materials progressed thoroughly. All in all, a mature histological appearance with slender trabeculae, formation of osteons, and residual fluorescence labels were evident for all materials after 1 year ( Fig. 5 ), even though bone formation in the Endobon™ samples showed a heterogeneous appearance with different maturity grades representing an ongoing remodelling (Tabs. I and IV).
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Histomorphometrical analysis
Both calcium phosphate cements showed a degradation of material over time. Bone Source™ showed a significant degradation in the beginning between the 6 and 12 week group (Tab. V). By comparison, Cementek™ was characterised by a linear degradation over all time intervals, with significant degradation between the 6-and 52week groups and consequently between the 12-and 52week groups. Bone formation into the defect area of both calcium phosphate cements reached a maximum after 12 weeks postoperatively at the defect sites. Bone Source™ showed a significant ingrowth between the 6-and 12week groups and between the 6-and 52-week groups. Cementek™ showed a significant ingrowth of bone between the 6-and 52-week groups.
The comparison of both calcium phosphate cements concerning bone formation and material degradation showed a significant difference after 52 weeks in favour of Cementek™.
The ceramic Endobon™ was characterised by a differ- Even though the ceramic Endobon™ was not degraded over time, there was naturally a significant difference in comparison with both calcium phosphate cements concerning residual material, in favour of En-dobon™ after 6 weeks. On the other hand, a significant difference between the ceramic and the cements could not be detected 12 weeks after implantation. After 52 weeks, residual material was significantly less detected in the Endobon™ group in comparison with the Bone Source™ group. Based on the linear degradation of Cementek™, residual material was, therefore, significantly less in the latter group in comparison with the Endobon™ group after 52 weeks. Bone formation after 6 and 52 weeks was significantly greater in the Endobon™ group in comparison with the Bone Source™ group, and in addition, the ceramic group surpassed significantly the Cementek™ group after 52 weeks (Tab. V).
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DISCUSSION
Study design
The Göttinger minipig is an established animal model for this type of experiment (22-28), because it emulates human physiological conditions. Control defects were omitted, as they had caused fractures at the critical size defect area in a previous study. A partial healing could be identified histologically (19) . Regarding statistical power requirements the sample size was calculated to be sufficient for statistical analysis (29) (30) (31) . The use of the internally rinsed tubular, hollow diamond milling cutter prevents heat necrosis at the interface, which provides a biologically intact osseous defect site, thereby preserving the full biological repair potential of the defect area (11). The cornerstone of this study was the possibility to examine 2 injectable bone substitute materials and a hydroxyapatite ceramic intraindividually based on random assignments, against each other in a biologically highly valuable animal model. This setting embodies an innovative environment for analysing these substances, which has not been described before.
Histological and histomorphometrical results: Bone Source™
Excellent bioactivity, biocompatibility, and osteoconductivity could be attributed to Bone Source™ after 6 we- a stable interface and a stable implantation site. The labelling showed clearly a centripetal osseous incorporation. Fibrous tissue did not seem to impede osseous incorporation and integration of Bone Source™ in any way. These conclusions were in accordance with those of Basle et al and our own observations (27, 28, 38 ). It appears that such an amount of fibrous tissue did not have a negative effect on osseous incorporation of Bone Source™. In this context, distance osteogenesis could rather be detected, which was described by Merten et al (31) . Since proper osteotransduction could not be observed, fibrous tissue functioned as a transient void filler (39).
Fig. 5 -Cementek™ at 52 weeks: prominent vascularisation which stands for angiogene osteogenesis can be detected (single-headed arrows); degradation of substitute material can still be identified by polynucleated cells (lines); osseous integration of the substitute particles is ubiquitous (double-headed arrows); and osteons in intimate contact with the particles verifies a mature incorporation (dotted lines) in spite of the evidence of sporadic woven bone (magnification ×100; toluidine blue staining).
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Histological and histomorphometrical results: Cementek™
Cementek™ was doubtless compacter than Bone Source™. The heterogeneous degree of material fragmentation of Bone Source™ was not observed for Cementek™. The degradation dynamics of both cements differed significantly. Cementek™ was degraded continuously over time, whereas stagnation of degradation was detected for Bone Source™ after 12 weeks. Therefore, a significant difference occurred after 1 year postoperatively in favour of Cementek™ (Tab. V). Regarding the chemical components of each cement, Bone Source™ consists partially of dical-eks postoperatively, based on the fact that broad-based osseous deposits could be detected in combination with a multitude of osteoblasts in intimate contact with the substitute (32) . The degree of fragmentation of the material was quite heterogeneous within all time interval groups, which was in accordance with the observations of Moghadam et al (32) . Possible reasons for this last characteristic are disturbances of the setting reaction during contact with tissue fluid, high and varying application pressure during implantation, or irritation based on relative movement of the overlying tissues (33-36). Since massive fragmentation was mainly observed in the 12-week group, which fostered bony ingrowth into the defect area consequently, the degree of bone formation had a peak after 12 weeks, with a reduction thereafter (Fig. 3) . Cellular resorption was indicated by polynucleated cells identified in intimate contact with the substitute surface (29) . A multitude of vessels could be detected. The vascularisation which indicates an angiogene osteogenesis could be identified histologically in all time intervals, especially in the 6-week group (29, 37) . The fluorescence labelling which highlighted the remodelling processes showed a mineralisation of the interface beginning at the second postoperative week. The fluorescence labelling did not differ relevantly between the 6-week and 12-week groups, which constituted both One-way analysis of variance and Tamhane T2 as post hoc test were applied for comparison of materials within each time group; Friedman's analysis of variance was applied for comparison of the follow-up groups of each material mature trabeculae, woven bone was still detected after 52 weeks. The typical slender and differentiated trabeculae which were identified in the defect sites of both cements were observed to a far lesser degree in the ceramic-treated defect sites. The remodelling seemed delayed in comparison with that in the defect areas treated with Bone Source™ and Cementek™. One reason for the delay of remodelling was the persistence of the ceramic cylinders. This was a striking observation and mainly based on the sintering process and the calcium phosphate ratio of the ceramic, which causes a rise of pH value at the interface (49). An unphysiologically raised pH value leads to a greatly reduced resorption of the ceramic (50). Furthermore, the persistence of the ceramic structures is promoted by a thorough osseous integration which prevents dissolution processes (4, 31). These characteristics are interrelated and prevent a completely adequate osseous healing of the defect site.
CONCLUSIONS
The excellent osseous integration which could be seen in the compound osteogenesis of Bone Source™ after 12 weeks postoperatively seemed to impede further profound degradation at the stable implantation site, because it both protected the globuli from cellular resorption processes and hampered chemical degradation (31). Similarly, a delayed and thorough compound osteogenesis was detected after 52 weeks for Cementek™, as well. The latter and the chemical composition of Cementek™ were mainly responsible for further degradation of this calcium phosphate cement. Thus, an outstanding bioactivity in combination with an excellent osteoconductivity led to a limited remodelling, with an expected persistence of both materials at the defect area. The ceramic Endobon™ excelled in bioactivity, biocompatibility, and osteoconductivity and consequently persisted after a year.
Biomechanically stable conditions, which (according to Wolff's law (51)) did not promote further degradation and remodelling around the defect area, led to these histological observations for both calcium phosphate cements. Persistence of the ceramic Endobon™ was additionally based on the sintering process and the degree of physicochemical release of ions at the interface depending on changes of pH value. These circumstances prevented a restitutio ad integrum of the defect area for all examined materials.
The calcium phosphate cements Bone Source™ and Cementek™ offer alternatives to autologous bone grafts to fill osseous defects at stable and well-vascularised implantation sites. In contrast, the ceramic Endobon™ should be used with caution because a complete persistence of the substitute and a delayed remodelling of the defect site were detected 1 year postoperatively. cium phosphate which is less soluble than α-tricalcium phosphate, a component of Cementek™ under physiological conditions (40). Furthermore, the greater degree of fragmentation of Bone Source™ led to thorough osseous incorporation of these particles, which seemed to impede further profound degradation at the stable implantation site, since it both protected the globuli from cellular resorption processes and hampered chemical degradation (Fig. 3) (31) . The differing chemical composition, histological characteristics and the higher microporosity of Cementek TM led to greater degradation of this substitute material (13, 15) .
Similar histological reactions and observations to those detected for Bone Source™ could also be identified for Cementek™. Regular remodelling processes with cellular degradation (Fig. 2) (29, 41) , excellent biocompatibility, osteoconductivity (41), and bioactivity (2, 42) could be attributed to Cementek™ without limitations (Fig. 5 ). Regarding the fibrous tissue reactions, the same observations and conclusions applied to Cementek™, as well. Over the time intervals, continuing remodelling led to a slender and mature trabecular structure, with many osteons which incorporated both Bone Source™ and Cementek™ completely ( Figs. 3 and 5 ). Bone formation in the defect area only differed significantly after 52 weeks between the 2 cements. The resorption dynamics were the most striking differences between the 2 products. This was attributed to the chemical composition and behaviour of each substance in situ. Therefore, diffusion effects should be taken into consideration. To prove the latter, earlier time interval groups ought to be planned for experiments dealing with such bone substitute materials in the future.
Histological and histomorphometrical results: Endobon™
The histological observations and characteristics of the Endobon™ samples were in accordance with the observations of Dingeldein et al (43), Roeser et al (44) , and Schnettler et al (45) . Great similarities to the histological observations for the Bone Source™ and Cementek™ groups could be detected, except for the absence of any degradation process. The ceramic revealed excellent bioactivity, biocompatibility, and osteoconductivity (Fig. 4) . Bone formation continued significantly over all time intervals. The last was even significant after 6 weeks in comparison with Bone Source™ and after 52 weeks in comparison with both cements in favour of the Endobon™ treated defects (Tab. V). Fluorescence labelling highlighted a centripetal osseous ingrowth using the ceramic trabeculae as a scaffold (Fig. 1) . The press-fit implantation of the Endobon™ cylinders was the prerequisite for a fast osseous incorporation (43, 46) . Nevertheless, the latter could only be achieved based on the great macroporosity of the ceramic cylinders, which provided a perfect scaffold (6, 47, 48) . Even though remodelling took place with the formation of
